Knowledge, attitudes, and practices of business travelers regarding influenza and the use of antiviral medication

Journal of Travel Medicine

Volumn 17, Issue 6, 2010, Pages 367-373

  Helfenberger, Salome ^a   Tschopp, Alois ^a   Robyn, Luc ^b   Hatz, Christoph ^a   Schlagenhauf, Patricia ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NESTLÉ RESEARCH CENTER   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; INFLUENZA VACCINE;

ARTICLE; ATTITUDE TO HEALTH; CLINICAL FEATURE; DISEASE TRANSMISSION; EMPORIATRICS; HEALTH BELIEF; HUMAN; MEDICAL SPECIALIST; QUESTIONNAIRE; SEASONAL INFLUENZA;

ADULT; ANTIVIRAL AGENTS; FEMALE; HEALTH BEHAVIOR; HEALTH EDUCATION; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; INTERNET; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SWITZERLAND; TRAVEL;

EID: 78349256199     PISSN: 11951982     EISSN: 17088305     Source Type: Journal    
DOI: 10.1111/j.1708-8305.2010.00467.x     Document Type: Article

References (25)

1. European Centre for Disease Prevention and Control (ECDC). 2009. Available at. (Accessed 2009 Dec 10)
2. Marti F, Steffen R, Mutsch M., Influenza vaccine: a travelers' vaccine? Expert Rev Vaccines 2008; 7: 679-687.
3. Mutsch M, Tavernini M, Marx A, et al., Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis 2005; 40: 1282-1287.
4. Nitsch-Osuch A., Influenza as a health problem of sea travelers. Int Marit Health 2008; 59: 103-112.
5. Mukherjee P, Lim PL, Chow A, et al., Epidemiology of travel-associated pandemic (H1N1) 2009 infection in 116 patients, Singapore. Emerg Infect Dis 2010; 16: 21-26.
6. Wagner BG, Coburn BJ, Blower S., Calculating the potential for within-flight transmission of influenza A (H1N1). BMC Med 2009; 7: 81.
7. Wilson ME, Weld LH, Boggild A, et al., Fever in returned travelers: results from the GeoSentinel Surveillance Network. Clin Infect Dis 2007; 44: 1560-1568.
8. Luna LK, Panning M, Grywna K, et al., Spectrum of viruses and atypical bacteria in intercontinental air travelers with symptoms of acute respiratory infection. J Infect Dis 2007; 195: 675-679.
9. Reichert T, Chowell G, Nishiura H, et al., Does glycosylation as a modifier of original antigenic sin explain the case age distribution and unusual toxicity in pandemic novel H1N1 influenza? BMC Infect Dis 2010; 10: 5.
10. Freedman DO, Leder K., Influenza: changing approaches to prevention and treatment in travelers. J Travel Med 2005; 12: 36-44.
11. Leder K, Sundararajan V, Weld L, et al., Respiratory tract infection in travelers: a review of the GeoSentinel Surveillance Network. Clin Infect Dis 2003; 36: 399-406.
12. Ansart S, Caumes E., Influenza and travelling. Med Mal Infect 2006; 36: 190-195.
13. Boggild AK, Castelli F, Gautret P, et al., Vaccine preventable diseases in returned international travelers: results from the GeoSentinel Surveillance Network. Vaccine 2010. doi:10.1016/j.vaccine.2010.09.009
14. Hsu CI, Shih HH., Transmission and control of an emerging influenza pandemic in a small-world airline network. Accid Anal Prev 2010; 42: 93 -100.
15. World Health Organization. WHO regional offices. 2010. Available at:. (Accessed 2010 Jul 07)
16. Petersen JE., Traveller's medicine on the internet. Ugeskr Laeger 2005; 167: 3971-3973. (Article in Danish)
17. Centers for Disease Control and Prevention (CDC). Travelers' health-yellow book. 2010. Available at. (Accessed 2010 Jan 26)
18. World Health Organization (WHO). International travel and health. 2009. Infectious diseases of potential risk for travelers. Available at. (Accessed 2010 Jan 26)
19. National Travel Health Network and Centre (NaTH NaC). Travel health information sheets. Seasonal influenza. 2008. Available at:. (Accessed 2010 Jan 26)
20. Centers for Disease Control and Prevention (CDC). Use of northern hemisphere influenza vaccines by travelers to the southern hemisphere. MMWR Morb Mortal Wkly Rep 2009; 58: 312.
21. Ciancio BC, Meerhoff TJ, Kramarz P, et al., Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses. Euro Surveill 2009; 14:pii=19412.
22. Dharan NJ, Gubareva LV, Meyer JJ, et al., Infections with oseltamivir-resistant influenza A (H1N1) virus in the United States. JAMA 2009; 301: 1034-1041.
23. Hurt AC, Holien JK, Parker M, et al., Zanamivir-resistant influenza viruses with a novel neuraminidase mutation. J Virol 2009; 83: 10366-10373.
24. Weinstock DM, Zuccotti G., The evolution of influenza resistance and treatment. JAMA 2009; 301: 1066-1069.
25. Moscona A., Global transmission of oseltamivir-resistant influenza. N Engl J Med 2009; 360: 953-956.